Clinical Trials Logo

Citation(s)

Is the Use of Fibrinogen in Cesarean Section Related to Bleeding and Blood Product in Patients With Placenta Accreta Spectrum?: a Retrospective Randomized Study

Details for clinical trial NCT05938062